Press Releases
| 2012 | |||
| 01/23/2012 | MS LIFELINES EARNS J.D. POWER AND ASSOCIATES CALL CENTER CERTIFICATION FOR CUSTOMER SERVICE EXCELLENCE IN PROVIDING SUPPORT SERVICES TO THE MS COMMUNITY Rockland, MA/New York, NY | English |
| 2011 | |||
| 10/19/2011 | EMD SERONO AND FAST FORWARD COMMIT $3 MILLION FOR MULTIPLE SCLEROSIS Rockland, Massachusetts | English | |
| 09/15/2011 | EMD SERONO, INC. HONORED AS A 2011 WORKING MOTHER 100 BEST COMPANY Rockland, Massachusetts | English | |
| 07/14/2011 | EMD SERONO, INC. ANNOUNCES APPOINTMENT OF JAMES HOYES AS PRESIDENT Rockland, Massachusetts | English | |
| 06/30/2011 | EMD SERONO, INC. AND FAST FORWARD, LLC ANNOUNCE RECIPIENTS OF FUNDING FOR MULTIPLE SCLEROSIS RESEARCH
Rockland, Massachusetts / New York, New York | English | |
| 06/23/2011 | EMD SERONO INC. COMMITTED TO TRANSPARENCY IN INTERACTIONS WITH HEALTHCARE PROFESSIONALS AND ORGANIZATIONS Rockland, Massachusetts | English | |
| 06/09/2011 | EMD SERONO: PATIENT ENROLLMENT COMPLETED FOR CILENGITIDE'S PIVOTAL PHASE III TRIAL CENTRIC Rockland, Massachusetts | English | |
| 05/20/2011 | EMD SERONO PRESIDENT AND CEO FEREYDOUN FIROUZ RESIGNS Rockland, Massachusetts | English | |
| 05/04/2011 | EMD SERONO, INC. ANNOUNCES CIVIL SETTLEMENT Rockland, Massachusetts | English | |
| 04/28/2011 | EMD SERONO, INC. PROVIDES $1.5M GRANT TO MASSACHUSETTS GENERAL Rockland, Massachusetts | English | |
| 04/26/2011 | EMD SERONO, INC. RECEIVES GOLD LEED RATING Rockland, Massachusetts | English | |
| 04/08/2011 | EMD SERONO'S COMMITMENT TO ADVANCE MULTIPLE SCLEROSIS CARE AND RESEARCH UNDERSCORED BY DATA TO BE PRESENTED AT AAN 2011 MEETING Rockland, Massachusetts | English | |
| 03/24/2011 | EMD SERONO, INC. RECEIVES CEO CANCER GOLD STANDARD™ ACCREDITATION Rockland, Massachusetts | English | |
| 03/02/2011 | EMD SERONO RECEIVES COMPLETE RESPONSE LETTER FROM FDA ON CLADRIBINE TABLETS NEW DRUG APPLICATION
Rockland, Massachusetts | English | |
| 02/10/2011 | EMD SERONO HOLDS GRAND OPENING CEREMONY FOR NEW STATE-OF-THE-ART RESEARCH CENTER IN BILLERICA, MA
Rockland, Massachusetts | English |
| 2010 | |||
| 11/26/2010 | EMD SERONO ANNOUNCES EXTENSION OF FDA PRIORITY REVIEW PERIOD FOR CLADRIBINE TABLETS FOR THE TREATMENT OF RELAPSING FORMS OF MULTIPLE SCLEROSIS
Rockland, Massachusetts | English | |
| 11/11/2010 | FDA APPROVES EGRIFTA (TESAMORELIN FOR INJECTION): FIRST AND ONLY TREATMENT FOR THE REDUCTION OF EXCESS ABDOMINAL FAT IN HIV-INFECTED PATIENTS WITH LIPODYSTROPHY Rockland, Massachusetts | English | |
| 10/08/2010 | EMD SERONO, INC. NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE Rockland, Massachusetts | English | |
| 09/01/2010 | MS LIFELINES REACHES MILESTONE OF SERVICING ONE MILLION IN-BOUND CALLS Rockland, Massachusetts | English | |
| 07/28/2010 | EMD SERONO, INC.: FDA GRANTS PRIORITY REVIEW TO CLADRIBINE TABLETS FOR THE TREATMENT OF RELAPSING FORMS OF MS Rockland, Massachusetts | English | |
| 06/17/2010 | EMD SERONO RESUMES STIMUVAX CLINICAL PROGRAM IN LUNG CANCER Rockland, Massachusetts | English | |
| 06/05/2010 | CILENGITIDE STUDY PROVIDES LONG-TERM FOLLOW-UP DATA IN GLIOBLASTOMA PATIENTS | English | |
| 05/05/2010 | EMD SERONO, INC. AND FAST FORWARD, LLC ANNOUNCE FIRST RESULTS OF THEIR COLLABORATION TO ADVANCE DRUG DEVELOPMENT IN MULTIPLE SCLEROSIS Rockland, Massachusetts | English | |
| 03/23/2010 | EMD SERONO: STIMUVAX CLINICAL PROGRAM TEMPORARILY SUSPENDED | English | |
| 03/05/2010 | EMD SERONO, INC. NAMED ONE OF THE BEST PLACES TO WORK IN INDUSTRY BY THE SCIENTIST MAGAZINE | English | |
| 1/21/2010 | TWO-YEAR RESULTS FROM CLARITY STUDY WITH CLADRIBINE TABLETS IN MULTIPLE SCLEROSIS PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE Rockland, Massachusetts | English | |
| 2009 | |||
| 12/16/2009 | EMD SERONO, INC. AND NATIONALLY RANKED US HOSPITAL ANNOUNCE COLLABORATION IN BASIC AND CLINICAL RESEARCH IN MULTIPLE SCLEROSIS Rockland, MA | English | |
| 11/30/2009 | EMD SERONO, INC. RECEIVES REFUSE TO FILE LETTER FROM FDA ON CLADRIBINE TABLETS NEW DRUG APPLICATION Rockland, MA | English | |
| 10/19/2009 | EMD SERONO, INC. HOLDS TOPPING OFF CEREMONY TO MARK MILESTONE IN EXPANSION OF THE COMPANY'S BILLERICA, MA RESEARCH FACILITY Rockland, MA | English | |
| 10/05/2009 | EMD SERONO, INC. NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE Rockland, MA | English | |
| 09/30/2009 | EMD SERONO SUBMITS APPLICATION FOR CLADRIBINE TABLETS AS A POTENTIAL ORAL SHORT-COURSE MULTIPLE SCLEROSIS THERAPY IN THE UNITED STATES Rockland, MA | English | |
| 08/10/2009 | EMD SERONO, INC. AND THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER ANNOUNCE COLLABORATION FOR PRECLINICAL RESEARCH, CLINICAL TRIALS
Rockland, MA/Houston, TX | English | |
| 05/27/2009 | MULTIPLE SCLEROSIS - WHAT ARE PEOPLE WITH MS AND THEIR HEALTH CARE PROVIDERS REALLY THINKING?
Rockland, MA/New York, NY | English | |
| 05/01/2009 | EMD Serono, Inc. and Fast Forward, LLC Commit $3 Million in 2009 To Early Stage Drug Development For Multiple Sclerosis
Rockland, MA/New York, NY | English | |
| 04/29/2009 | TWO-YEAR PHASE III DATA PRESENTED AT AAN 61ST ANNUAL MEETING SHOW POSITIVE OUTCOME OF CLADRIBINE TABLETS IN PATIENTS WITH MULTIPLE SCLEROSIS
| English | |
| 03/30/2009 | EMD SERONO: NEW PHASE III DATA FOR CLADRIBINE TABLETS TO BE PRESENTED AT THE AMERICAN ACademY OF NEUROLOGY 61ST ANNUAL MEETING IN APRIL 2009
Rockland, Massachusetts | English | |
| 03/30/2009 | EMD SERONO ANNOUNCES EXPANSION WITH RESEARCH SITE IN CAMBRIdGE, MASSACHUSETTS
| English | |
| 03/18/2009 | EMD SERONO and Fast Forward, LLC Announce Collaboration to Accelerate Development of Treatments for Multiple Sclerosis Rockland, Massachusetts | English | |
| 01/23/2009 | EMD SERONO’S ORAL INVESTIGATIONAL TREATMENT CLADRIBINE TABLETS FOR MULTIPLE SCLEROSIS SIGNIFICANTLY REDUCED RELAPSE RATE IN TWO-YEAR PHASE III PIVOTAL TRIAL
Rockland, Massachusetts | English | |
| 01/12/2009 | EMD Serono and Emmaus Medical Announce Promotional Rights Agreement for Zorbtive® in the United States
| English |
| 2008 | |||
| 11/07/2008 | EMD SERONO LAUNCHES LANDMARK PATIENT REGISTRY FOR EGG FREEZING Rockland, Massachusetts | English | |
| 10/29/2008 | EMD SERONO AND THERATECHNOLOGIES ANNOUNCE COLLABORATION AND LICENSING AGREEMENT FOR TESAMORELIN IN THE UNITED STATES Rockland, Massachusetts | English | |
| 10/9/2008 | EMD SERONO NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE Rockland, Massachusetts | English | |
| 7/10/2008 | EMD SERONO, INC. TO ADOPT REVISED AND STRENGTHENED PHRMA CODE Rockland, Massachusetts | English | |
| 4/16/2008 | EMD SERONO ANNOUNCES PLANNED INVESTMENT OF $50 MILLION IN RESEARCH CENTER IN MASSACHUSETTS Geneva, Switzerland | English |
| 2007 | |||
| 12/13/2007 | EMD ANNOUNCES SUPPORT OF THE MICHAEL J. FOX FOUNDATION FOR PARKINSON’S RESEARCH
Geneva, Switzerland | English | |
| 12/6/2007 | EMD SERONO LAUNCHES EASYPOD®, NEW ELECTRONIC GROWTH HORMONE INJECTION DEVICEGeneva, Switzerland | English | |
| 7/2/2007 | EMD SERONO LAUNCHES MS LIFELINES ACCESS MADE SIMPLE, A PROGRAM DESIGNED TO SIMPLIFY ACCESS TO MS THERAPY
Rockland, Massachusetts | English |
| 2007 | |||
| 6/4/2007 | MERCK SERONO S.A. TO TERMINATE REGISTRATION AND DUTY TO FILE REPORTS UNDER THE U.S. SECURITIES EXCHANGE ACT
Geneva, Switzerland | English | |
| 6/4/2007 | CLOSING OF THE EXISTING SHARE-REPURCHASE PROGRAM OF UP TO CHF 750 MILLION BY JUNE 1, 2007 Geneva, Switzerland | English | |
| 4/5/2007 | MERCK SERONO S.A. TO VOLUNTARILY DELIST AND DEREGISTER ITS BEARER SHARES AND AMERICAN DEPOSITARY SHARES (EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS) Geneva, Switzerland | English | |
| 3/21/2007 | MERCK INITIATES SQUEEZE OUT PROCEDURE FOR SHARES OF MERCK SERONO S.A. Geneva, Switzerland | English | |
| 3/21/2007 | MERCK SERONO CONFIRMS PREVIOUSLY ANNOUNCED 2006 FIGURES Geneva, Switzerland | English | |
| 2/28/2007 | MERCK KGAA HOLDS NEARLY ALL VOTING RIGHTS IN MERCK SERONO S.A. Geneva, Switzerland | English | |
| 1/9/2007 | MERCK KGaA ANNOUNCES PUBLIC TENDER OFFER FOR MERCK SERONO SHARES Geneva, Switzerland | English | |
| 1/8/2007 | MERCK SERONO IS LAUNCHED Geneva, Switzerland | English | |
| 1/5/2007 | MERCK KGAA ACQUIRES MARJORITY SHAREHOLDING IN SERONO S.A. Geneva, Switzerland | English |
| Disclaimer |
| This site contains medical information that is intended for residents of the United States only and is not meant to be a substitute for the advice provided by a medical professional. Always consult a healthcare provider if you have health concerns. For residents outside of the US, please go to www.merckserono.com for information. |
